logo

For the Inventor, By the Inventor

Tsukuba, Japan

Yasufumi Nagata

This inventor holds 8 USPTO granted patents. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1994-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasufumi Nagata. Retrieved from https://idiyas.com/inventor/yasufumi-nagata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Tokyo, JP (1994 - 1995)
  • Tsukuba, JP (1995 - 2007)

Company Filing History:

goldMedal8 out of 237 
 
Banyu Pharmaceutical Co. Ltd
 patents

Years Active: 1994-2007

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7253188 - Aminobenzamide derivative (2007-08-07),
2. 5777150 - Substituted amic acid derivatives (1998-07-07),
3. 5616803 - Substituted amic acid derivatives (1997-04-01),
4. 5606101 - Substitute amic acid derivatives (1997-02-25),
5. 5488149 - Substituted amic acid derivatives (1996-01-30),
6. 5439932 - Substituted amine derivatives having anti-hyperlipemia activity (1995-08-08),
7. 5405873 - Substituted acetamide derivatives (1995-04-11),
8. 5306728 - Substituted amine derivatives having antihyperlipemia activity (1994-04-26),

Title: **Innovations of Yasufumi Nagata: Pioneering Pharmacological Discoveries**

Introduction

Yasufumi Nagata, an innovative inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 8 patents, his work focuses on developing compounds with potential therapeutic applications, particularly in treating diabetes mellitus and related complications.

Latest Patents

Among his latest inventions is a novel compound known as an aminobenzamide derivative. This innovative compound features a unique formula and exhibits a glucokinase activation effect. It holds promise for treating and preventing diabetes mellitus as well as its complications, which include diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, and diabetic arteriosclerosis.

Another noteworthy patent is related to substituted amic acid derivatives. This compound, represented by a specific formula, includes a variety of substituents and groups that enhance its pharmacological properties. The versatility of this compound shows potential for further research in medicinal applications.

Career Highlights

Yasufumi Nagata's career at Banyu Pharmaceutical Co. Ltd. has been marked by a dedication to advancing pharmaceutical research and innovation. His expertise in chemical compounds has positioned him as a key figure in the development of new treatments that can significantly impact patient care.

Collaborations

Throughout his career, Yasufumi has worked alongside talented colleagues such as Yoshikazu Iwasawa and Takashi Nomoto. These collaborations have not only enriched his research but have also led to groundbreaking advancements in the pharmaceutical industry.

Conclusion

Yasufumi Nagata continues to make strides in pharmaceutical innovation, focusing on compounds that promise to improve health outcomes for individuals with diabetes. His numerous patents reflect his commitment to scientific progress and his drive to enhance therapeutic options through inventive solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…